TNFRSF4 Antikörper
Kurzübersicht für TNFRSF4 Antikörper (ABIN610382)
Target
Alle TNFRSF4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Human CD134 Molecule of about 35 kd. BerAct35 does not block the interaction between CD134(OX40) and CD252(OX40L).
-
Aufreinigung
- Protein A purified
-
Immunogen
-
Human HUT 102 T cells.
Type of Immunogen: Cells -
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 50 mM sodium phosphate, pH 7.5, 100 mM potassium chloride, 150 mM sodium chloride, 0.5 mg/mL Gentamicin sulfate
-
Konservierungsmittel
- Gentamicin sulfate
-
Vorsichtsmaßnahmen
- This product contains Gentamicin sulfate: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8°C for up to 1 year. Avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
-
: "Lipid rafts are required for GLUT4 internalization in adipose cells." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 21, pp. 12050-5, (2001) (PubMed).
: "The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, Issue 7, pp. 3712-7, (1999) (PubMed).
-
-
- TNFRSF4 (Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
-
Andere Bezeichnung
- TNFRSF4 / CD134 / OX40
-
Hintergrund
-
Name/Gene ID: TNFRSF4
Family: TNF Receptor
Synonyms: TNFRSF4, ACT35 antigen, ATC35 antigen, CD134, ACT35, OX40, OX40 antigen, OX40L receptor, OX40 homologue, CD134 antigen, OX40 cell surface antigen, TXGP1L -
Gen-ID
- 7293
-
UniProt
- P43489
-
Pathways
- Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Target
-